Decade Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
BFA
BIT
Decade Capital Management's CRL Position: Q1 2015 in Review
Decade Capital Management sold out of Charles River Laboratories (CRL) in Q1 2015, closing a stake of 140 shares — an estimated $9K sold.
Decade Capital Management first reported a position in CRL in Q1 2014 and held it in 2 quarters. The position peaked at $6.26M in Q1 2014. 259 funds tracked by Wall St. Rank hold CRL as of Q1 2015.
- Decade Capital Management reported no remaining Charles River Laboratories position as of Q1 2015 after selling out during the quarter.
- Decade Capital Management sold 140 Charles River Laboratories shares in Q1 2015, an estimated $9K.
- Decade Capital Management first reported a position in Charles River Laboratories in Q1 2014 and held it in 2 quarters.
- Decade Capital Management's Charles River Laboratories position peaked at $6.26M in Q1 2014.
- 259 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2015.
Based on Decade Capital Management's 13F filing for Q1 2015, filed 15 May 2015.